Exosomal survivin facilitates vesicle internalization

Amber Gonda, Janviere Kabagwira, Girish N. Senthil, Heather R. Ferguson Bennit, Jonathan W. Neidigh, Salma Khan, Nathan R. Wall

Research output: Contribution to journalArticlepeer-review

Abstract

Survivin, a member of the inhibitor of apoptosis (IAP) protein family plays a significant role in cell fate and function. It is significantly overexpressed in tumor cells and has been identified in most cancer cell types. A novel extracellular population has recently been identified and its function is still unknown. Emerging evidence continues to shed light on the important role the tumor microenvironment (TME) has on tumor survival and progression. This new population of survivin has been seen to enhance the tumor phenotype when internalized by recipient cells. In this paper, we sought to better understand the mechanism by which survivin is taken up by cancer cells and the possible role it plays in this phenomenon. We isolated the exosomal carriers of extracellular survivin and using a lipophilic stain, PKH67, we tracked their uptake with immunofluorescence and flow cytometry. We found that by blocking exosomal survivin, exosome internalization is reduced, signifying a novel function for this protein. We also discovered that the common membrane receptors, transferrin receptor, endothelin B receptor, insulin receptor alpha, and membrane glucocorticoid receptor all facilitate exosomal internalization. This understanding further clarifies the protein-protein interactions in the TME that may influence tumor progression and identifies additional potential chemotherapeutic targets.

Original languageEnglish
Pages (from-to)34919-34934
Number of pages16
JournalOncotarget
Volume9
Issue number79
DOIs
StatePublished - Oct 2018

ASJC Scopus Subject Areas

  • Oncology

Keywords

  • cancer targets
  • exosome
  • membrane receptors
  • survivin
  • transferrin

Cite this